SPY411.39-0.10 -0.02%
DIA337.47-0.40 -0.12%
IXIC13,845.21-54.98 -0.40%

Rubius Therapeutics Expects Gross Proceeds of About $200M From Share Sale

Rubius Therapeutics Expects Gross Proceeds of About $200M From Share Sale

· 03/16/2021 21:32

Please log in to view news